Table 4.
Marine-derived compounds in phase I status.
Compound Name | Marine Organism |
Chemical Class | Molecular Target (Target Hallmarks) |
Cancer Type | References |
---|---|---|---|---|---|
MORAb-202 | Sponge | ADC (macrolide) |
Microtubules | Solid tumors | [8,88,89] |
XMT-1536 | Mollusk/ cyanobacterium |
ADC (dolaflexin) |
NaPi2b and microtubules | Solid tumors | [8,90,91,92,93,94] |
RF06804103 | Mollusk/ cyanobacterium |
ADC (auristatin variant) |
HER2 | Breast neoplasms, stomach neoplasms, esophagogastric junction neoplasm, carcinoma, non-small-cell lung cancer | [8,95,96,97,98] |
ARX-788 | Mollusk/ cyanobacterium |
ADC (MMAE) |
HER2 and microtubules | Breast cancer, gastric cancer | [8,99,100,101] |
ALT-P7 | Mollusk/ cyanobacterium |
ADC (MMAE) |
HER2 and microtubules | Breast cancer, gastric cancer | [8,102,103] |
ZW49 | Mollusk/ cyanobacterium |
ADC (auristatin variant) |
HER2 | HER2-expressing cancers | [8,104] |